SynthesisBMC cardiovascular disorders2024

Long-term surrogate cardiovascular outcomes of SGLT2 inhibitor empagliflozin in chronic heart failure: a systematic review and meta-analysis.

Qingkai Yan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.